Advancing the impact of clinical diagnostics in healthcare by effectively developing and delivering innovative solutions that address significant unmet operational and medical needs in immunoassays, microbiology, and molecular biology, to help combat the rise of antimicrobial resistance and better manage acute conditions linked to infections.

Expanding syndromic testing technology outside traditional clinical laboratories to the point-of-care settings to provide patients with fast answers, while giving clinicians the information they need to make timely, targeted treatment decisions - contributing to the fight against antimicrobial resistance.

As a leading provider of augmented diagnostics for smarter and more dynamic risk assessment, we help our customers provide consumers safe products of the highest quality. Through rigorous science, technology, expertise and data science, we are committed to move from test results to true actionable insights.

We help the pharmaceutical industry through our expertise and our innovative suite of solutions, providing rapid and highly accurate methods. Our integrated offer easily adapts to our customers’ facilities, products, and processes, to ultimately provide critical therapies to patients quickly and safely.